Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts.
Blood Cancer Discov. 2022 Jul 6;3(4):270-272. doi: 10.1158/2643-3230.BCD-22-0046.
Myelodysplastic syndrome (MDS) describes a family of blood disorders driven by the clonal expansion of mutated blood cells that can evolve into secondary acute myeloid leukemia (sAML). Two new studies use single-cell and deep sequencing to elucidate the progression of MDS to AML, revealing discrete clonal architectures and the driving role of signaling mutations.
骨髓增生异常综合征 (MDS) 是一组由突变血细胞克隆性扩增引起的血液疾病,可进展为继发性急性髓系白血病 (sAML)。两项新的研究使用单细胞和深度测序来阐明 MDS 向 AML 的进展,揭示了离散的克隆结构和信号突变的驱动作用。